{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:30:59Z","timestamp":1793745059015,"version":"4.6.1"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:00:00Z","timestamp":1714089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Malignant mesothelioma is a rare form of cancer that mostly affects the pleura and has a strong link to asbestos exposure. Greece banned the use of asbestos in 2005, however, the public was already aware of this substance in the 1980s. This research aims to present an overview of Greece\u2019s mesothelioma age-standardized mortality rates (ASMR) from 1983 to 2019 by age, gender, and geographic region and to determine whether the actions to ban asbestos impacted these rates.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were retrieved by the Hellenic Statistical Authority (HSA) from death certificates that mentioned mesothelioma as the cause of death from 1983 to 2019 with details on the residence, gender, and age. Statistical analysis was performed using PRISM 6.0 software, a two-way ANOVA test, Trend analysis was conducted using Joinpoint Regression Program 5.0 software. The linear and non-linear model was used to calculate the age-standardized rates of annual percentage change (APC) and its 95% confidential interval (95% CI).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>From 1983 to 2019, 850 total mesothelioma deaths were recorded, the majority of whom were males (634). A rate of 74.6% accounts for males and 25.4% for females, and the ratio of Males: Females was 3:1. Males\u2019 ASMR and the whole population\u2019s ASMR reached their highest levels in 2011 (0.93\/100000person-years and 0.53\/100000person-years, respectively). To look for potential changes between the first two decades of the 21st century, we compared the mean ASMR of each geographic region in Greece between two different 10-year subperiods (2000\u20132009 and 2010\u20132019). Except for Epirus, all regions of Greece had elevated regional ASMRs, particularly in those with the highest asbestos deposits. Notably, the ASMR in Epirus decreased from 0.54\/100000person-years (2000\u20132009) to 0.31\/100000person-years (2010\u20132019). After 2011, the ASMR for men and the general population stabilized. This stability is important since mesothelioma in men is associated with occupational asbestos exposure. The intriguing discovery of a lower ASMR in Epirus emphasizes the need to raise awareness of the condition and implement effective public health measures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In Greece, the annual ASMR for males and the whole population reached its highest level in 2011, which is positive and encouraging and may be a sign that the rate will stabilize during the following years. Moreover, this study showed that the actions made in the 1980s regarding public awareness and surveillance directly impacted the decrease in Epirus rates. Future research, continual awareness, information, and recording are needed to monitor the mesothelioma epidemic. The possible benefit of a mesothelioma registry and the epidemiological surveillance of asbestos-related diseases, particularly mesothelioma mortality, need to be addressed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12889-024-18030-x","type":"journal-article","created":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T09:02:19Z","timestamp":1714122139000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Asbestos ban policies and mesothelioma mortality in Greece"],"prefix":"10.1186","volume":"24","author":[{"given":"Evdoxia","family":"Gogou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chryssi","family":"Hatzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Siachpazidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios G.","family":"Zarogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos I.","family":"Gourgoulianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,26]]},"reference":[{"issue":"142","key":"18030_CR1","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1183\/16000617.0063-2016","volume":"25","author":"AC Bibby","year":"2016","unstructured":"Bibby AC, Tsim S, Kanellakis N, Ball H, Talbot DC, Blyth KG, et al. Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment. Eur Respir Rev. 2016;25(142):472\u201386. https:\/\/doi.org\/10.1183\/16000617.0063-2016","journal-title":"Eur Respir Rev"},{"key":"18030_CR2","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1136\/oemed-2019-105826","volume":"76","author":"D Consonni","year":"2019","unstructured":"Consonni D, Calvi C, Matteis S De, Mirabelli D, Landi MT, Caporaso NE, et al. Peritoneal mesothelioma and asbestos exposure: a population-based case\u2013 control study in Lombardy, Italy. Occup. Environ Med. 2019;76:545\u201353.","journal-title":"Occup. Environ Med"},{"issue":"6","key":"18030_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.5271\/sjweh.3895","volume":"46","author":"A Marinaccio","year":"2020","unstructured":"Marinaccio A, Consonni D, Mensi C, Mirabelli D, Migliore E, Magnani C, et al. Association between asbestos exposure and pericardial and tunica vaginalis testis malignant mesothelioma: a case\u2013control study and epidemiological remarks. Scand J Work Environ Health. 2020;46(6):609\u201317.","journal-title":"Scand J Work Environ Health"},{"issue":"2","key":"18030_CR4","first-page":"32","volume":"9","author":"A Bridda","year":"2007","unstructured":"Bridda A, Padoan I, Mencarelli R, and Frego M. Peritoneal mesothelioma: a review. MedGenMed. 2007;9(2):32.","journal-title":"MedGenMed"},{"key":"18030_CR5","doi-asserted-by":"publisher","first-page":"200226","DOI":"10.1183\/16000617.0226-2020","volume":"30","author":"R Asciak","year":"2021","unstructured":"Asciak R, George V, and Rahman NM. Update on biology and management of mesothelioma. Eur Respir Rev. 2021;30:200226. https:\/\/doi.org\/10.1183\/16000617.0226-2020","journal-title":"Eur Respir Rev"},{"issue":"6","key":"18030_CR6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.jtho.2023.01.095","volume":"18","author":"J Huang","year":"2023","unstructured":"Huang J, Chan SC, Pang WS, Chow SH, Lok V, Zhang L, et al. Global incidence, risk factors, and temporal trends of mesothelioma: a population-based study. J Thorac Oncol. 2023;18(6):792\u2013802.","journal-title":"J Thorac Oncol"},{"key":"18030_CR7","unstructured":"Forman D, Bray F, Brewster DH, Gombe MBalawa C, Kohler B, Pineros M, et al. Cancer incidence in five continents vol. X. IARC Scientific Publications. 2014;No 164."},{"issue":"7","key":"18030_CR8","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.jtho.2017.04.002","volume":"12","author":"B Liu","year":"2017","unstructured":"Liu B, van Gerwen M, Bonassi S, and Taioli E. Epidemiology of environmental exposure and malignant mesothelioma. J Thorac Oncol. 2017;12(7):1031\u201345. https:\/\/doi.org\/10.1016\/j.jtho.2017.04.002","journal-title":"J Thorac Oncol"},{"issue":"11","key":"18030_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.21037\/atm.2017.03.74","volume":"5","author":"CW Noonan","year":"2017","unstructured":"Noonan CW. Environmental asbestos exposure and risk of mesothelioma. Ann Transl Med. 2017;5(11):234.","journal-title":"Ann Transl Med"},{"issue":"Suppl 1","key":"18030_CR10","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.21037\/tlcr.2019.11.11","volume":"9","author":"N Alpert","year":"2020","unstructured":"Alpert N, van Gerwen M, and Taioli E. Epidemiology of mesothelioma in the 21st century in Europe and the United States, 40 years after restricted\/banned asbestos use. Transl Lung Cancer Res. 2020;9(Suppl 1):S28\u201338.","journal-title":"Transl Lung Cancer Res"},{"key":"18030_CR11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0140-6736(07)60412-7","volume":"369","author":"RT Lin","year":"2007","unstructured":"Lin RT, Takahashi K, Karjalainen A, Hoshuyama T, Wilson D, Kameda T, et al. Ecological association between asbestos-related diseases and historical asbestos consumption: an international analysis. Lancet. 2007;369:844\u201349.","journal-title":"Lancet"},{"issue":"6","key":"18030_CR12","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.jtho.2023.03.013","volume":"18","author":"M Carbone","year":"2023","unstructured":"Carbone M, Yang H, Pass HI, and Taioli E. Did the ban on asbestos reduce the incidence of mesothelioma? J Thorac Oncol. 2023;18(6):694\u201397. https:\/\/doi.org\/10.1016\/j.jtho.2023.03.013","journal-title":"J Thorac Oncol"},{"issue":"8","key":"18030_CR13","doi-asserted-by":"publisher","first-page":"e2120360","DOI":"10.1001\/jamanetworkopen.2021.20360","volume":"4","author":"Z Zhai","year":"2021","unstructured":"Zhai Z, Ruan J, Zheng Y, Xiang D, Li N, Hu J, et al. Assessment of global trends in the diagnosis of mesothelioma from 1990 to 2017. JAMA Network Open. 2021;4(8):e2120360.","journal-title":"JAMA Network Open"},{"key":"18030_CR14","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.3390\/ijms21196987","volume":"21","author":"N Kumagai-Takei","year":"2020","unstructured":"Kumagai-Takei N, Lee S, Srinivas B, Shimizu Y, Sada N, Yoshitome K, et al. The effects of asbestos fibers on human T cells. Int J Mol Sci. 2020;21:6987. https:\/\/doi.org\/10.3390\/ijms21196987","journal-title":"Int J Mol Sci"},{"key":"18030_CR15","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1183\/09059180.00007014","volume":"24","author":"OD R\u00f8e","year":"2015","unstructured":"R\u00f8e OD, and Stella GM. Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic. Eur Respir Rev. 2015;24:115\u201331. https:\/\/doi.org\/10.1183\/09059180.00007014","journal-title":"Eur Respir Rev"},{"key":"18030_CR16","doi-asserted-by":"publisher","unstructured":"Sporn TA. Mineralogy of asbestos. In: A. Tannapfel (ed.), Malignant mesothelioma, recent results in cancer research 189. 2011. https:\/\/doi.org\/10.1007\/978-3-642-10862-4_1","DOI":"10.1007\/978-3-642-10862-4_1"},{"issue":"6","key":"18030_CR17","doi-asserted-by":"publisher","first-page":"753","DOI":"10.5858\/arpa.2017-0365-RA","volume":"142","author":"RL Attanoos","year":"2018","unstructured":"Attanoos RL, Churg A, Galateau-Salle F, Gibbs AR, and Roggli VL. Malignant mesothelioma and its non-asbestos causes. Arch Pathol Lab Med. 2018;142(6):753\u201360.","journal-title":"Arch Pathol Lab Med"},{"issue":"6","key":"18030_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/ajim.22985","volume":"62","author":"D Loomis","year":"2019","unstructured":"Loomis D, Richardson DB, and Elliott L. Quantitative relationships of exposure to chrysotile asbestos and mesothelioma mortality. Am J Ind Med. 2019;62(6):471\u201377. https:\/\/doi.org\/10.1002\/ajim.22985","journal-title":"Am J Ind Med"},{"key":"18030_CR19","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1002\/(SICI)1097-0274(199609)30:3<252::AID-AJIM2>3.0.CO;2-0","volume":"30","author":"AH Smith","year":"1996","unstructured":"Smith AH, and Wright CC. Chrysotile asbestos is the main cause of pleural mesothelioma. Am J Ind Med. 1996;30:252\u201366.","journal-title":"Am J Ind Med"},{"issue":"1","key":"18030_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1111\/j.2164-0947.1965.tb02195.x","volume":"132","author":"Annals of the New York Academy of Sciences","year":"1965","unstructured":"Annals of the New York Academy of Sciences. Biological effects of asbestos. 1965;132(1):5\u2013705. https:\/\/doi.org\/10.1111\/j.2164-0947.1965.tb02195.x","journal-title":"Biological Effects of Asbestos"},{"key":"18030_CR21","unstructured":"IARC monographs on the evaluation of the carcinogenic risk to humans: asbestos. 1977;14. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK419324\/"},{"key":"18030_CR22","unstructured":"IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans: silica and some silicates. 1987;42. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK410052\/"},{"key":"18030_CR23","unstructured":"IARC monographs on the evaluation of carcinogenic risks to humans: arsenic, metals, and dust. 2012;100\u00a0C."},{"key":"18030_CR24","unstructured":"Amand-Eeckhout L. EU legislation in progress: protection of workers from asbestos at work. Eur Parliam Res Serv Introd. 2023;PE 749.813."},{"key":"18030_CR25","doi-asserted-by":"publisher","unstructured":"Virta RL. Worldwide asbestos supply and consumption trends from1900 through 2003. US Geological Survey Circular. US Geological Survey Circular 1298. 2006;80p. https:\/\/doi.org\/10.3133\/cir1298","DOI":"10.3133\/cir1298"},{"key":"18030_CR26","unstructured":"Laurie Kazan-Allen. London Asbestos meetings, April 2002. International ban Asbestos secretariat. 2002. http:\/\/ibasecretariat.org\/lka_london_meetings_rep_0402.php (last accessed on 28 Dec 2023)"},{"key":"18030_CR27","unstructured":"Laurie Kazan-Allen. Chronology of asbestos bans and restrictions. International Ban Asbestos Secretariat. 2023. http:\/\/ibasecretariat.org\/chron_ban_list.php (last accessed on 28 Dec 2023)"},{"key":"18030_CR28","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1023\/A:1026300619747","volume":"14","author":"F Montanaro","year":"2003","unstructured":"Montanaro F, Bray F, Gennaro V, Merler E, Tyczynski JE, Parkin DM, et al. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes and Control. 2003;14:791\u2013803.","journal-title":"Cancer Causes and Control"},{"key":"18030_CR29","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1136\/thoraxjnl-2021-217709","volume":"77","author":"JP Van Kooten","year":"2022","unstructured":"Van Kooten JP, Belderbos RA, Von Der Th\u00fcsen JH, Aarts MJ, Verhoef C, Burgers JA, et al. Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study. Thorax. 2022;77:1260\u201367.","journal-title":"Thorax"},{"issue":"4","key":"18030_CR30","doi-asserted-by":"publisher","first-page":"e14605","DOI":"10.7759\/cureus.14605","volume":"13","author":"A Thomas","year":"2021","unstructured":"Thomas A, Karakattu S, Cagle J, and Hoskere G. Malignant pleural mesothelioma epidemiology in the United States from 2000 to 2016. Cureus. 2021;13(4):e14605. https:\/\/doi.org\/10.7759\/cureus.14605","journal-title":"Cureus"},{"key":"18030_CR31","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1186\/s12885-021-08913-2","volume":"21","author":"K Hemminki","year":"2021","unstructured":"Hemminki K, F\u00f6rsti A, Chen T, and Hemminki A. Incidence, mortality and survival in malignant pleural mesothelioma before and after asbestos in Denmark, Finland, Norway and Sweden. BMC Cancer. 2021;21:1189. https:\/\/doi.org\/10.1186\/s12885-021-08913-2","journal-title":"BMC Cancer"},{"issue":"1","key":"18030_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.5334\/aogh.4012","volume":"89","author":"C Gariazzo","year":"2023","unstructured":"Gariazzo C, Gasparrini A, and Marinaccio A. Asbestos consumption and malignant mesothelioma mortality trends in the major user countries. Ann Glob Heal. 2023;89(1):11. https:\/\/doi.org\/10.5334\/aogh.4012","journal-title":"Ann Glob Heal"},{"key":"18030_CR33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ijc.20552","volume":"113","author":"A Burdorf","year":"2005","unstructured":"Burdorf A, Jarvholm B, and Englunt A. Explaining differences in incidence rates of pleural mesothelioma between Sweden and the Netherlands. Int J Cancer. 2005;113:298\u2013301.","journal-title":"Int J Cancer"},{"key":"18030_CR34","doi-asserted-by":"publisher","first-page":"101441","DOI":"10.1016\/j.ssmph.2023.101441","volume":"23","author":"W Zhu","year":"2023","unstructured":"Zhu W, Liu J, Li Y, Shi Z, and Wei S. Global, regional, and national trends in mesothelioma burden from 1990 to 2019 and the predictions for the next two decades. SSM - Popul Heal. 2023;23:101441. https:\/\/doi.org\/10.1016\/j.ssmph.2023.101441","journal-title":"SSM - Popul Heal"},{"issue":"6","key":"18030_CR35","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1742-1241.2007.01334.x","volume":"63","author":"E Gogou","year":"2009","unstructured":"Gogou E, Kerenidi T, Chamos V, Zintzaras E, and Gourgoulianis KI. Mesothelioma mortality in Greece from 1983 to 2003. Int J Clin Pract. 2009;63(6):944\u20138.","journal-title":"Int J Clin Pract"},{"issue":"8","key":"18030_CR36","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.3390\/medicina55080419","volume":"55","author":"E Gogou","year":"2019","unstructured":"Gogou E, Hatzoglou C, Zarogiannis SG, Malli F, Jagirdar RM, and Gourgoulianis KI. Mesothelioma mortality rates in Greece for the period 2005\u20132015 is increased compared to previous decades. Medicina. 2019;55(8):e419. https:\/\/doi.org\/10.3390\/medicina55080419","journal-title":"Medicina"},{"key":"18030_CR37","unstructured":"Virta, RL. Asbestos. U.S. Geological survey minerals yearbook 2007. 2008;8.1\u20138.6. http:\/\/minerals.usgs.gov\/minerals\/pubs\/commodity\/asbestos\/myb1-2007-asbes.pdf (last accessed on December 30 2023)"},{"issue":"2","key":"18030_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0013-9351(85)90096-9","volume":"38","author":"SH Constantopoulos","year":"1985","unstructured":"Constantopoulos SH, Goudevenos JA, Saratzis N, Langer AM, Selikoff IJ, and Moutsopoulos HM. Metsovo lung: pleural calcification and restrictive lung function in northwestern Greece. Environmental exposure to mineral fiber as etiology. Environ Res. 1985;38(2):319\u201331.","journal-title":"Environ Res"},{"issue":"2","key":"18030_CR39","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0013-9351(85)90088-X","volume":"38","author":"T Bazas","year":"1985","unstructured":"Bazas T, Oakes D, Gilson JC, Bazas B, and McDonald JC. Pleural calcification in northwest Greece. Environ Res. 1985;38(2):239\u201347.","journal-title":"Environ Res"},{"key":"18030_CR40","unstructured":"https:\/\/www.opendata.nhs.scot\/dataset\/standard-populations\/resource\/edee9731-daf7-4e0d-b525-e4c1469b8f69. Standard Populations - European Standard Population (last accessed on 29 Dec 2023)."},{"issue":"4","key":"18030_CR41","first-page":"491","volume":"1","author":"BM Robinson","year":"2012","unstructured":"Robinson BM. Malignant pleural mesothelioma: an epidemiological perspective. Ann Cardiothorac Surg. 2012;1(4):491\u201396.","journal-title":"Ann Cardiothorac Surg"},{"key":"18030_CR42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.puhe.2021.04.008","volume":"195","author":"A Scarselli","year":"2021","unstructured":"Scarselli A, Marinaccio A, and Iavicoli S. Ophiolitic outcrops, naturally occurring asbestos exposure and mortality risk from malignant mesothelioma in Calabria (Southern Italy). Public Health. 2021;195:57\u201360. https:\/\/doi.org\/10.1016\/j.puhe.2021.04.008","journal-title":"Public Health"},{"key":"18030_CR43","doi-asserted-by":"publisher","first-page":"101791","DOI":"10.1016\/j.canep.2020.101791","volume":"68","author":"JS Torres-Roman","year":"2020","unstructured":"Torres-Roman JS, Gomez-Rubio V, Sanchez-Trujillo L, Delgado-Rosas E, Puche-Vergara F, Sanz-Anquela JM, et al. Geographic study of mortality due to mesothelioma in Peru and its evolution. Cancer Epidemiol. 2020;68:101791. https:\/\/doi.org\/10.1016\/j.canep.2020.101791","journal-title":"Cancer Epidemiol"},{"issue":"1","key":"18030_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1111\/j.1440-1843.2007.01187.x","volume":"13","author":"M Metintas","year":"2008","unstructured":"Metintas M, Metintas S, Ak G, Erginel S, Alatas F, Kurt E, et al. Epidemiology of pleural mesothelioma in a population with non-occupational asbestos exposure. Respirology. 2008;13(1):117\u201321.","journal-title":"Respirology"},{"issue":"6","key":"18030_CR45","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1440-1843.2008.01373.x","volume":"13","author":"E Gogou","year":"2008","unstructured":"Gogou E, Kerenidi T, Chamos V, Hatzoglou C, and Gourgoulianis KI. Environmental asbestos exposure alters the male: female ratio in patients with pleural mesothelioma. Respirology. 2008;13(6):931.","journal-title":"Respirology"},{"key":"18030_CR46","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/ajim.23257","volume":"64","author":"X Baur","year":"2021","unstructured":"Baur X, Frank AL, Soskolne CL, Oliver LC, and Magnani C. Malignant mesothelioma: ongoing controversies about its etiology in females. Am J Ind Med. 2021;64:543\u201350.","journal-title":"Am J Ind Med"},{"key":"18030_CR47","doi-asserted-by":"publisher","unstructured":"Gogou E, Zarogiannis SG, Siachpazidou D, Hatzoglou C, and Gourgoulianis KI. Causes and pathogenesis of malignant mesothelioma. In: Strumfa I (editor) Mesothelioma - diagnostics, treatment and basic research. IntechOpen. 2022. https:\/\/doi.org\/10.5772\/intechopen.103669","DOI":"10.5772\/intechopen.103669"},{"issue":"8","key":"18030_CR48","first-page":"214","volume":"66","author":"JM Mazurek","year":"2017","unstructured":"Mazurek JM, Syamlal G, Wood JM, Hendricks SA, and Weston A. Malignant mesothelioma mortality \u2014 United States, 1999\u20132015. MMWR. 2017;66(8):214\u20138.","journal-title":"MMWR"},{"key":"18030_CR49","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2471\/BLT.11.086678","volume":"89","author":"V Delgermaa","year":"2011","unstructured":"Delgermaa V, Takahashi K, Park EK, Le GV, Hara T, and Sorahan T. Global mesothelioma deaths reported to the World Health Organization between 1994 and 2008. Bull World Health Organ. 2011;89:716\u201324C. https:\/\/doi.org\/10.2471\/BLT.11.086678","journal-title":"Bull World Health Organ"},{"key":"18030_CR50","first-page":"147","volume":"33","author":"ML Newhouse","year":"1976","unstructured":"Newhouse ML, and Berry G. Predictions of mortality from mesothelial tumours in asbestos factory workers. British J Industrial Medicine. 1976;33:147\u201351.","journal-title":"British J Industrial Medicine"},{"key":"18030_CR51","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/bjc.1982.15","volume":"45","author":"J Peto","year":"1982","unstructured":"Peto J, Seidman H, and Selikoff IJ. Mesothelioma in asbestos workers: implications for models of carcinogenesis and risk assessment. Br J Cancer. 1982;45:124\u201335.","journal-title":"Br J Cancer"},{"key":"18030_CR52","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1136\/oem.2003.008128","volume":"61","author":"G Berry","year":"2004","unstructured":"Berry G, de Klerk NH, Reid A, Ambrosini GL, Fritschi L, N J Olsen NJ, et al. Malignant pleural and peritoneal mesotheliomas in former miners and millers of crocidolite at Wittenoom, Western Australia. Occup Env Med. 2004;61:e14. http:\/\/www.occenvmed.com\/cgi\/content\/full\/61\/4\/e14(last accessed on 17 Dec 2023).","journal-title":"Occup Env Med"},{"key":"18030_CR53","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1136\/oem.2006.028258","volume":"63","author":"JC McDonald","year":"2006","unstructured":"McDonald JC, Harris JM, and Berry G. Sixty years on: the price of assembling military gas masks in 1940. Occup Env Med. 2006;63:852\u201355.","journal-title":"Occup Env Med"},{"key":"18030_CR54","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1002\/ajim.20844","volume":"53","author":"AH Harding","year":"2010","unstructured":"Harding AH, and Darnton AJ. Asbestosis and mesothelioma among British Asbestos workers (1971\u20132005). Am J Ind Med. 2010;53:1070\u201380.","journal-title":"Am J Ind Med"},{"key":"18030_CR55","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12940-019-0510-6","volume":"18","author":"F Luberto","year":"2019","unstructured":"Luberto F, Ferrante D, Silvestri S, Angelini A, Cuccaro F, Nannavecchia AM, et al. Cumulative asbestos exposure and mortality from asbestos related diseases in a pooled analysis of 21 asbestos cement cohorts in Italy. Environ Health. 2019;18:71. https:\/\/doi.org\/10.1186\/s12940-019-0510-6 (last accessed on 17 Dec 2023).","journal-title":"Environ Health"},{"key":"18030_CR56","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/oem.60.1.50","volume":"60","author":"O Segura","year":"2003","unstructured":"Segura O, Burdorf A, and Looman C. Update of predictions of mortality from pleural mesothelioma in the Netherlands. Occup Environ Med. 2003;60:50\u201355.","journal-title":"Occup Environ Med"},{"issue":"3\/4","key":"18030_CR57","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","volume":"79","author":"J Peto","year":"1999","unstructured":"Peto J, Decarli A, La Vecchia C, Levi F, and Negri E. The European mesothelioma epidemic. British J Cancer. 1999;79(3\/4):666\u201372.","journal-title":"British J Cancer"},{"key":"18030_CR58","doi-asserted-by":"publisher","unstructured":"Fazzo L, Binazzi A, Ferrante D, Minelli G, Consonni D, Bauleo L, et al. Burden of mortality from asbestos-related diseases in italy. Int J Environ Res Public Health. 2021;18:10012. https:\/\/doi.org\/10.3390\/ijerph181910012 (last accessed on 3 May 2023).","DOI":"10.3390\/ijerph181910012"},{"key":"18030_CR59","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.3390\/cancers13133338","volume":"13","author":"E Oddone","year":"2021","unstructured":"Oddone E, Bollon J, Nava CR, Consonni D, Marinaccio A, Magnani C, et al. Effect of asbestos consumption on malignant pleural mesothelioma in Italy: forecasts of mortality up to 2040. Cancers. 2021;13:3338. https:\/\/doi.org\/10.3390\/cancers13133338 (last accessed on 2 May 2023).","journal-title":"Cancers"},{"issue":"5\u20136","key":"18030_CR60","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1080\/10937404.2016.1194254","volume":"19","author":"MJ Soeberg","year":"2016","unstructured":"Soeberg MJ, Leigh J, and van Zandwijk N. Malignant mesothelioma in Australia 2015: current incidence and asbestos exposure trends. J Toxicol Environ Health - Part B Crit Rev. 2016;19(5\u20136):173\u201389. https:\/\/doi.org\/10.1080\/10937404.2016.1194254","journal-title":"J Toxicol Environ Health - Part B Crit Rev"},{"key":"18030_CR61","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.shaw.2022.04.006","volume":"13","author":"E Algranti","year":"2022","unstructured":"Algranti E, Santana VS, Campos F, Salvi L, Saito CA, Cavalcante F, et al. Analysis of mortality from asbestos-related diseases in Brazil using multiple health information systems, 1996\u20132017. Saf Health Work. 2022;13:302\u20137. https:\/\/doi.org\/10.1016\/j.shaw.2022.04.006","journal-title":"Saf Health Work"},{"key":"18030_CR62","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/oemed-2016-104119","volume":"75","author":"A Marinaccio","year":"2018","unstructured":"Marinaccio A, Corfiati M, Binazzi A, Di Marzio D, Scarselli A, Ferrante P, et al. The epidemiology of malignant mesothelioma in women: gender differences and modalities of asbestos exposure. Occup Environ Med. 2018;75:254\u201362.","journal-title":"Occup Environ Med"},{"issue":"3","key":"18030_CR63","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nrc3459","volume":"13","author":"M Carbone","year":"2013","unstructured":"Carbone M, Yang H, Pass HI, Krausz T, Testa JR, and Gaudino G. BAP1 and cancer. Nat Rev Cancer. 2013;13(3):153\u201359.","journal-title":"Nat Rev Cancer"},{"key":"18030_CR64","doi-asserted-by":"crossref","unstructured":"Carbone M, Kanodia S, Chao A, Miller A, Wali A, Weissman D, et al. Consensus report of the 2015 Weinman international conference on mesothelioma. J Thorac Oncol. 2016;11(8):1246\u201362.","DOI":"10.1016\/j.jtho.2016.04.028"},{"issue":"12","key":"18030_CR65","doi-asserted-by":"publisher","first-page":"4327","DOI":"10.3390\/ijms21124327","volume":"21","author":"V Panou","year":"2020","unstructured":"Panou V, and R\u00f8e OD. Inherited genetic mutations and polymorphisms in malignant mesothelioma: a comprehensive review. Int J Mol Sci. 2020;21(12):4327.","journal-title":"Int J Mol Sci"},{"issue":"35","key":"18030_CR66","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1200\/JCO.2018.79.0352","volume":"36","author":"S Pastorino","year":"2018","unstructured":"Pastorino S, Yoshikawa Y, Pass HI, Emi M, Nasu M, Pagano I, et al. A subset of mesotheliomas with improved survival occurring in carriers of BAP1 and other germline mutations. J Clin Oncol. 2018;36(35):3485\u201394.","journal-title":"J Clin Oncol"},{"issue":"10","key":"18030_CR67","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1158\/1535-7163.MCT-16-0229","volume":"15","author":"S Kato","year":"2016","unstructured":"Kato S, Tomson BN, Buys TPH, Elkin SK, Carter JL, and Kurzrock R. Genomic landscape of malignant mesotheliomas. Mol Cancer Ther. 2016;15(10):2498\u2013507.","journal-title":"Mol Cancer Ther"},{"key":"18030_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mrrev.2019.03.001","volume":"781","author":"M Betti","year":"2019","unstructured":"Betti M, Aspesi A, Sculco M, Matullo G, Magnani C, and Dianzani I. Genetic predisposition for malignant mesothelioma: a concise review. Mutat Res - Rev Mutat Res. 2019;781:1\u201310. https:\/\/doi.org\/10.1016\/j.mrrev.2019.03.001","journal-title":"Mutat Res - Rev Mutat Res"},{"issue":"3","key":"18030_CR69","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/j.athoracsur.2014.04.040","volume":"98","author":"E Taioli","year":"2014","unstructured":"Taioli E, Wolf AS, Camacho-Rivera M, and Flores RM. Women with malignant pleural mesothelioma have a threefold better survival rate than men. Ann Thorac Surg. 2014;98(3):1020\u201324. https:\/\/doi.org\/10.1016\/j.athoracsur.2014.04.040","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"18030_CR70","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/carcin\/bgu227","volume":"36","author":"F Baumann","year":"2015","unstructured":"Baumann F, Flores E, Napolitano A, Kanodia S, Taioli E, Pass H, et al. Mesothelioma patients with germline BAP1 mutations have 7-fold improved long-term survival. Carcinogenesis. 2015;36(1):76\u201381.","journal-title":"Carcinogenesis"},{"issue":"6","key":"18030_CR71","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1183\/09031936.96.09061206","volume":"9","author":"K Sakellariou","year":"1996","unstructured":"Sakellariou K, Malamou-Mitsi V, Haritou A, Koumpaniou C, Stachouli C, Dimoliatis ID, et al. Malignant pleural mesothelioma from nonoccupational asbestos exposure in Metsovo (north-west Greece): slow end of an epidemic? Eur Respir J. 1996;9(6):1206\u201310.","journal-title":"Eur Respir J"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-024-18030-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-024-18030-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T21:06:48Z","timestamp":1714165608000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-024-18030-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,26]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["18030"],"URL":"https:\/\/doi.org\/10.1186\/s12889-024-18030-x","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3369279\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,26]]},"assertion":[{"value":"19 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Hellenic Statistical Authority (HAS) gave the data under strict confidentiality conditions and based on the study\u2019s design; it was stated that no ethical committee approval was necessary.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1177"}}